EEF1A1 and Familial prostate cancer: If the findings are validated in a larger cohort of patients, then the detection of eEF1A1 in the serum of patients with prostate cancer at the time of their initial diagnosis, may be able to predict the likelihood of disease progression and those patients be offered radical treatment options at an early stage of their disease.